CERo Therapeutics (CERO) Institutional Ownership $0.89 +0.00 (+0.21%) Closing price 04:00 PM EasternExtended Trading$0.88 -0.02 (-1.88%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for CERo Therapeutics (NASDAQ:CERO)CurrentInstitutional OwnershipPercentage29.64%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$55.20MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.83M Get CERO Insider Trade Alerts Want to know when executives and insiders are buying or selling CERo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CERo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/29/2025 Avantax Planning Partners Inc.74,321$54K0.0%-97.1%2.453% 4/8/2025 Parallel Advisors LLC220,000$161K0.0%N/A7.261% 2/17/2025ARCH Venture Management LLC9,393,561$564K0.2%+550.4%626.237% 2/7/2025 Avantax Planning Partners Inc.2,585,151$155K0.0%+89.9%171.999% (Data available from 1/1/2016 forward) CERO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CERO shares? During the previous two years, the following institutional investors and hedge funds held shares of CERo Therapeutics shares: ARCH Venture Management LLC ($564K), and Parallel Advisors LLC ($161K), Avantax Planning Partners Inc. ($54K).Learn more on CERO's institutional investors. What percentage of CERo Therapeutics stock is owned by institutional investors? 29.64% of CERo Therapeutics stock is owned by institutional investors. Learn more on CERO's institutional investor holdings. Which institutional investors have been buying CERo Therapeutics stock? The following institutional investors have purchased CERo Therapeutics stock in the last 24 months: ARCH Venture Management LLC ($7.95M), Avantax Planning Partners Inc. ($1.22M), and Parallel Advisors LLC ($220K). How much institutional buying is happening at CERo Therapeutics? Institutional investors have bought a total of 9,393,286 shares in the last 24 months. This purchase volume represents approximately $55.20M in transactions. Which CERo Therapeutics major shareholders have been selling company stock? The following institutional investors have sold CERo Therapeutics stock in the last 24 months: Avantax Planning Partners Inc. ($2.51M). How much institutional selling is happening at CERo Therapeutics? Institutional investors have sold a total of 2,510,830 shares in the last 24 months. This volume of shares sold represents approximately $1.83M in transactions. Related Companies CTXR Major Shareholders TSBX Major Shareholders CYCN Major Shareholders BFRI Major Shareholders ADXN Major Shareholders MYNZ Major Shareholders RNAZ Major Shareholders OMGA Major Shareholders INDP Major Shareholders AIM Major Shareholders This page (NASDAQ:CERO) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CERo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CERO Stock Free CERO Stock Alerts